VICTORIA CAMMACK: Open Payments
NPI 1376224246 · FRANKFORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,121 in 100 payments from 27 companies in 2025. Trend: 2023 $1,118 · 2024 $2,418 · 2025 $2,121
Food & beverage: $1,942Education: $179
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $233 |
| Incyte Corporation | 8 | $209 |
| Novartis Pharmaceuticals Corporation | 11 | $195 |
| AstraZeneca Pharmaceuticals LP | 6 | $164 |
| Janssen Biotech, Inc. | 8 | $148 |
| Merck Sharp & Dohme LLC | 6 | $133 |
| Daiichi Sankyo Inc. | 5 | $126 |
| Celgene Corporation | 5 | $115 |
| E.R. Squibb & Sons, L.L.C. | 6 | $101 |
| Eisai Inc. | 6 | $96 |
Products named: VENCLEXTA, OPDIVO, KEYTRUDA, KISQALI, Lenvima, ZEPZELCA, JAKAFI, TALVEY.
Industry payments across KY — which companies pay providers there.
